ALKEM LABORATORIES
Back to Income Statement
|
ALKEM LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹12,965 Cr | ₹12,668 Cr | ₹11,599 Cr | ₹10,634 Cr | ₹8,865 Cr |
What is the latest Revenue of ALKEM LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹12,965 Cr |
| Mar2024 | ₹12,668 Cr |
| Mar2023 | ₹11,599 Cr |
| Mar2022 | ₹10,634 Cr |
| Mar2021 | ₹8,865 Cr |
How is Revenue of ALKEM LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹12,965 Cr | 2.34 | |
| Mar2024 | ₹12,668 Cr | 9.21 | |
| Mar2023 | ₹11,599 Cr | 9.08 | |
| Mar2022 | ₹10,634 Cr | 19.96 | |
| Mar2021 | ₹8,865 Cr | - | |
Compare Revenue of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹62,751.1 Cr | 0.1% | -5.4% | 6.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,150.0 Cr | -0.9% | -3.9% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,129.0 Cr | -0.4% | -7.6% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,312.0 Cr | -2% | -7.5% | 27.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,445.2 Cr | -1.5% | -9.3% | 3.8% | Stock Analytics | |
| CIPLA | ₹98,210.2 Cr | 1.7% | -8.3% | -16.8% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 0.1% |
-5.4% |
6.8% |
| SENSEX | 7.8% |
-2% |
0.2% |
You may also like the below Video Courses